276 related articles for article (PubMed ID: 10648729)
1. The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation.
Hurley RW; Hammond DL
J Neurosci; 2000 Feb; 20(3):1249-59. PubMed ID: 10648729
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms responsible for the enhanced antinociceptive effects of micro-opioid receptor agonists in the rostral ventromedial medulla of male rats with persistent inflammatory pain.
Sykes KT; White SR; Hurley RW; Mizoguchi H; Tseng LF; Hammond DL
J Pharmacol Exp Ther; 2007 Aug; 322(2):813-21. PubMed ID: 17494863
[TBL] [Abstract][Full Text] [Related]
3. Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury.
Hurley RW; Hammond DL
J Neurosci; 2001 Apr; 21(7):2536-45. PubMed ID: 11264327
[TBL] [Abstract][Full Text] [Related]
4. Persistent inflammatory pain decreases the antinociceptive effects of the mu opioid receptor agonist DAMGO in the locus coeruleus of male rats.
Jongeling AC; Johns ME; Murphy AZ; Hammond DL
Neuropharmacology; 2009; 56(6-7):1017-26. PubMed ID: 19265713
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception.
Schepers RJ; Mahoney JL; Shippenberg TS
Pain; 2008 Jun; 136(3):320-330. PubMed ID: 17764840
[TBL] [Abstract][Full Text] [Related]
6. Blockade of opioid receptors in rostral ventral medulla prevents antihyperalgesia produced by transcutaneous electrical nerve stimulation (TENS).
Kalra A; Urban MO; Sluka KA
J Pharmacol Exp Ther; 2001 Jul; 298(1):257-63. PubMed ID: 11408550
[TBL] [Abstract][Full Text] [Related]
7. Cornea-responsive medullary dorsal horn neurons: modulation by local opioids and projections to thalamus and brain stem.
Hirata H; Takeshita S; Hu JW; Bereiter DA
J Neurophysiol; 2000 Aug; 84(2):1050-61. PubMed ID: 10938327
[TBL] [Abstract][Full Text] [Related]
8. Selective opioid delta agonists elicit antinociceptive supraspinal/spinal synergy in the rat.
Kovelowski CJ; Bian D; Hruby VJ; Lai J; Ossipov MH; Porreca F
Brain Res; 1999 Oct; 843(1-2):12-7. PubMed ID: 10528105
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
10. Highly delta selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO.
Hirakawa N; Tershner SA; Fields HL
Neuroreport; 1999 Oct; 10(15):3125-9. PubMed ID: 10574547
[TBL] [Abstract][Full Text] [Related]
11. Different effects of NMDA/group I metabotropic glutamate receptor agents in delta- and mu-opioid receptor agonist-induced supraspinal antinociception.
Suzuki T; Aoki T; Ohnishi O; Nagase H; Narita M
Eur J Pharmacol; 2000 May; 396(1):23-8. PubMed ID: 10822049
[TBL] [Abstract][Full Text] [Related]
12. Implications of phosphoinositide 3-kinase in the mu- and delta-opioid receptor-mediated supraspinal antinociception in the mouse.
Narita M; Ohnishi O; Nemoto M; Yajima Y; Suzuki T
Neuroscience; 2002; 113(3):647-52. PubMed ID: 12150784
[TBL] [Abstract][Full Text] [Related]
13. Antihyperalgesic effects of delta opioid agonists in a rat model of chronic inflammation.
Fraser GL; Gaudreau GA; Clarke PB; Ménard DP; Perkins MN
Br J Pharmacol; 2000 Apr; 129(8):1668-72. PubMed ID: 10780972
[TBL] [Abstract][Full Text] [Related]
14. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
15. Spinal pharmacology of antinociception produced by microinjection of mu or delta opioid receptor agonists in the ventromedial medulla of the rat.
Hurley RW; Banfor P; Hammond DL
Neuroscience; 2003; 118(3):789-96. PubMed ID: 12710986
[TBL] [Abstract][Full Text] [Related]
16. A critical period in the supraspinal control of pain: opioid-dependent changes in brainstem rostroventral medulla function in preadolescence.
Hathway GJ; Vega-Avelaira D; Fitzgerald M
Pain; 2012 Apr; 153(4):775-783. PubMed ID: 22325744
[TBL] [Abstract][Full Text] [Related]
17. Multiple opioid receptors mediate feeding elicited by mu and delta opioid receptor subtype agonists in the nucleus accumbens shell in rats.
Ragnauth A; Moroz M; Bodnar RJ
Brain Res; 2000 Sep; 876(1-2):76-87. PubMed ID: 10973595
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
19. Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.
Gendron L; Esdaile MJ; Mennicken F; Pan H; O'Donnell D; Vincent JP; Devi LA; Cahill CM; Stroh T; Beaudet A
Neuroscience; 2007 Jan; 144(1):263-74. PubMed ID: 17055663
[TBL] [Abstract][Full Text] [Related]
20. Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla.
Heinricher MM; Morgan MM; Tortorici V; Fields HL
Neuroscience; 1994 Nov; 63(1):279-88. PubMed ID: 7898652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
